Literature DB >> 19895596

Time to locoregional recurrence after curative resection of rectal carcinoma is prolonged after neoadjuvant treatment: a systematic review and meta-analysis.

S Merkel1, U Mansmann, W Hohenberger, P Hermanek.   

Abstract

AIM: A systematic review of the literature with meta-analysis was performed to evaluate the time to locoregional recurrence after curative resection of rectal carcinoma, assuming that this time is prolonged after neoadjuvant radiochemotherapy and/or present day surgery.
METHOD: English and German language peer-reviewed articles published between 1980 and 2007 were selected. Twenty-five of 118 studies fulfilled the defined inclusion and exclusion criteria. For some special questions, data of the Erlangen Registry of Colorectal Carcinoma (ERCRC) from 1985 to 1997 are reported.
RESULTS: After conventional surgery of rectal carcinoma, 75% (range 66-84%) of locoregional recurrence presented during the first 2 years after resection. Following the introduction of total mesorectal excision surgery and the use of neoadjuvant treatment, a general reduction of the frequency of local recurrence combined with a prolongation of the time to local recurrence was observed. In the practice of today, in particular after neoadjuvant long-course radiochemo-or radiotherapy, 24% (range 8-40%) of all local recurrences present later than 5 years after primary therapy. In contrast, such late local recurrences are observed in only 8% (range 5-9%) following primary surgery alone.
CONCLUSION: For a definite assessment of the therapeutic results regarding local control, a minimal follow up of 7-8 years either after neoadjuvant long-course radiochemo- or radiotherapy and a minimum of 5 years after surgery alone is necessary. For patients with primary surgery followed by adjuvant therapy, it is not possible to make a clear statement.
© 2010 The Authors. Colorectal Disease © 2010 The Association of Coloproctology of Great Britain and Ireland.

Entities:  

Mesh:

Year:  2011        PMID: 19895596     DOI: 10.1111/j.1463-1318.2009.02110.x

Source DB:  PubMed          Journal:  Colorectal Dis        ISSN: 1462-8910            Impact factor:   3.788


  17 in total

1.  Impact of PET/CT for Restaging Patients With Locally Advanced Rectal Cancer After Neoadjuvant Chemoradiation.

Authors:  Eric Sorenson; Fernando Lambreton; Jian Q Yu; Tianyu Li; Crystal S Denlinger; Joshua E Meyer; Elin R Sigurdson; Jeffrey M Farma
Journal:  J Surg Res       Date:  2019-06-21       Impact factor: 2.192

2.  A hundred patients with vertical rectus abdominis myocutaneous (VRAM) flap for pelvic reconstruction after total pelvic exenteration.

Authors:  R E Horch; W Hohenberger; A Eweida; U Kneser; K Weber; A Arkudas; S Merkel; J Göhl; J P Beier
Journal:  Int J Colorectal Dis       Date:  2014-04-22       Impact factor: 2.571

3.  Survival analysis in rectal carcinoma after neoadjuvant chemoradiation: various methods with different results.

Authors:  Susanne Merkel; Klaus Weber; Jonas Göhl; Abbas Agaimy; Rainer Fietkau; Werner Hohenberger; Robert Grützmann; Paul Hermanek
Journal:  Int J Colorectal Dis       Date:  2017-07-20       Impact factor: 2.571

4.  Laparoscopic total mesorectal excision for extraperitoneal rectal cancer: long-term results of a 18-year single-centre experience.

Authors:  Riccardo Brachet Contul; Manuela Grivon; Massimiliano Fabozzi; Paolo Millo; Mario Junior Nardi; Stefania Aimonetto; Umberto Parini; Rosaldo Allieta
Journal:  J Gastrointest Surg       Date:  2014-01-18       Impact factor: 3.452

5.  Evaluation of quality indicators following implementation of total mesorectal excision in primarily resected rectal cancer changed future management.

Authors:  Paul M Schneider; Daniel Vallbohmer; Yvonne Ploenes; Georg Lurje; Ralf Metzger; Frederike C Ling; Jan Brabender; Uta Drebber; Arnulf H Hoelscher
Journal:  Int J Colorectal Dis       Date:  2011-02-22       Impact factor: 2.571

6.  Volume and outcome in rectal cancer surgery: the importance of quality management.

Authors:  Werner Hohenberger; Susanne Merkel; Paul Hermanek
Journal:  Int J Colorectal Dis       Date:  2012-11-10       Impact factor: 2.571

7.  Ezrin expression in rectal cancer predicts time to development of local recurrence.

Authors:  Fredrik Jörgren; Mef Nilbert; Eva Rambech; Pär-Ola Bendahl; Gudrun Lindmark
Journal:  Int J Colorectal Dis       Date:  2012-01-12       Impact factor: 2.571

8.  Pattern of rectal cancer recurrence after curative surgery.

Authors:  Minna Räsänen; Monika Carpelan-Holmström; Harri Mustonen; Laura Renkonen-Sinisalo; Anna Lepistö
Journal:  Int J Colorectal Dis       Date:  2015-03-22       Impact factor: 2.571

Review 9.  Colorectal cancer surveillance: what's new and what's next.

Authors:  Johnie Rose; Knut Magne Augestad; Gregory S Cooper
Journal:  World J Gastroenterol       Date:  2014-02-28       Impact factor: 5.742

Review 10.  Risk factors for local recurrence following neoadjuvant chemoradiotherapy for rectal cancers.

Authors:  Jia-Yuan Peng; Zhong-Nan Li; Yu Wang
Journal:  World J Gastroenterol       Date:  2013-08-28       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.